Details for New Drug Application (NDA): 079137
✉ Email this page to a colleague
NDA 079137 describes VALACYCLOVIR HYDROCHLORIDE, which is a drug marketed by Aiping Pharm Inc, Apotex, Aurobindo Pharma, Chartwell Rx, Cipla, Hetero Labs Ltd V, Hikma, Jubilant Generics, Mylan Pharms Inc, Pharmobedient, Rising, Sun Pharm Inds Ltd, Teva Pharms, Watson Labs Inc, Yiling, and Zydus Lifesciences, and is included in sixteen NDAs. It is available from forty suppliers. Additional details are available on the VALACYCLOVIR HYDROCHLORIDE profile page.
The generic ingredient in VALACYCLOVIR HYDROCHLORIDE is valacyclovir hydrochloride. There are twenty-three drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the valacyclovir hydrochloride profile page.
The generic ingredient in VALACYCLOVIR HYDROCHLORIDE is valacyclovir hydrochloride. There are twenty-three drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the valacyclovir hydrochloride profile page.
Summary for 079137
| Tradename: | VALACYCLOVIR HYDROCHLORIDE |
| Applicant: | Zydus Lifesciences |
| Ingredient: | valacyclovir hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 500MG BASE | ||||
| Approval Date: | Dec 29, 2017 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 1GM BASE | ||||
| Approval Date: | Dec 29, 2017 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
